Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,140 | 752 | 90.6% |
| Consulting Fee | $1,200 | 1 | 6.7% |
| Travel and Lodging | $304.49 | 1 | 1.7% |
| Education | $66.30 | 10 | 0.4% |
| Gift | $60.00 | 1 | 0.3% |
| Debt forgiveness | $43.24 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $2,619 | 113 | $0 (2024) |
| Biohaven Pharmaceutical Holding Company Ltd. | $2,195 | 31 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $2,083 | 65 | $0 (2024) |
| Gilead Sciences, Inc. | $1,460 | 32 | $0 (2024) |
| Amarin Pharma Inc. | $1,370 | 82 | $0 (2023) |
| Novo Nordisk Inc | $939.54 | 40 | $0 (2024) |
| Merck Sharp & Dohme LLC | $786.84 | 59 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $767.17 | 42 | $0 (2024) |
| Lilly USA, LLC | $760.27 | 52 | $0 (2024) |
| PFIZER INC. | $644.12 | 47 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,324 | 107 | AstraZeneca Pharmaceuticals LP ($541.04) |
| 2023 | $2,702 | 122 | Amgen Inc. ($495.77) |
| 2022 | $4,816 | 156 | Biohaven Pharmaceutical Holding Company Ltd. ($2,195) |
| 2021 | $2,272 | 118 | Amgen Inc. ($411.91) |
| 2020 | $1,124 | 65 | Gilead Sciences, Inc. ($221.29) |
| 2019 | $1,754 | 81 | Amgen Inc. ($410.18) |
| 2018 | $1,625 | 63 | Amgen Inc. ($328.81) |
| 2017 | $1,198 | 54 | Amgen Inc. ($200.53) |
All Payment Transactions
766 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.35 | General |
| Category: Inflammation | ||||||
| 12/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $10.51 | General |
| Category: Cardio-renal | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: PAIN | ||||||
| 12/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 12/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.38 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $10.69 | General |
| Category: PAIN | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $11.22 | General |
| Category: Cardio-renal | ||||||
| 11/06/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: DIABETES MEDICINE | ||||||
| 11/05/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.71 | General |
| Category: VACCINE | ||||||
| 10/30/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: Oncology | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Diabetes | ||||||
| 10/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.44 | General |
| 10/24/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: DIABETES MEDICINE | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $11.38 | General |
| Category: Cardio-renal | ||||||
| 10/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: Inflammation | ||||||
| 10/15/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: Cardio-renal | ||||||
| 10/15/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Diabetes Care | ||||||
| 10/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: Bone Health | ||||||
| 10/10/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: PAIN | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 62 | 4,330 | 8,246 | $1.3M | $285,247 |
| 2022 | 74 | 5,155 | 11,473 | $1.9M | $421,627 |
| 2021 | 75 | 5,469 | 11,628 | $1.9M | $448,370 |
| 2020 | 71 | 4,599 | 8,968 | $1.3M | $307,708 |
All Medicare Procedures & Services
282 procedure records from CMS Medicare Utilization — Page 1 of 12
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 294 | 817 | $334,980 | $72,407 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 250 | 701 | $248,880 | $43,992 | 17.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 148 | 148 | $66,600 | $18,525 | 27.8% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 34 | 408 | $40,800 | $11,405 | 28.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 124 | 261 | $31,320 | $10,968 | 35.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 244 | 342 | $51,300 | $9,921 | 19.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 36 | 57 | $26,790 | $7,460 | 27.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 34 | 204 | $20,400 | $7,242 | 35.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 253 | 431 | $38,790 | $7,094 | 18.3% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 33 | 185 | $18,500 | $6,602 | 35.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 23 | 23 | $15,200 | $6,477 | 42.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 267 | 476 | $45,220 | $6,232 | 13.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 273 | 521 | $33,865 | $5,392 | 15.9% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 41 | 81 | $16,200 | $4,933 | 30.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 272 | 551 | $11,020 | $4,612 | 41.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 230 | 310 | $24,800 | $4,582 | 18.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 253 | 436 | $21,800 | $4,141 | 19.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 25 | 25 | $11,850 | $3,964 | 33.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 267 | 452 | $22,600 | $3,440 | 15.2% |
| 86769 | Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | Office | 2023 | 81 | 83 | $16,600 | $3,427 | 20.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 26 | 26 | $20,800 | $3,415 | 16.4% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 40 | 42 | $16,800 | $3,415 | 20.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 21 | 22 | $19,800 | $3,084 | 15.6% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 12 | 15 | $3,750 | $2,097 | 55.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 68 | 69 | $3,450 | $2,044 | 59.2% |
About Yan Li, M.D., PH.D
Yan Li, M.D., PH.D is a Family Medicine healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619932076.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Yan Li, M.D., PH.D has received a total of $17,814 in payments from pharmaceutical and medical device companies, with $2,324 received in 2024. These payments were reported across 766 transactions from 62 companies. The most common payment nature is "Food and Beverage" ($16,140).
As a Medicare-enrolled provider, Li has provided services to 19,553 Medicare beneficiaries, totaling 40,315 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 282 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Plano, TX
- Active Since 04/19/2006
- Last Updated 11/28/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1619932076
Products in Payments
- NURTEC ODT (Drug) $2,717
- Vascepa (Drug) $1,370
- FARXIGA (Drug) $931.99
- BREZTRI (Drug) $815.28
- EVENITY (Biological) $749.72
- Vemlidy (Drug) $695.08
- JARDIANCE (Drug) $614.70
- Prolia (Biological) $590.00
- Otezla (Drug) $584.36
- Kerendia (Drug) $558.36
- JANUVIA (Drug) $519.43
- Aimovig (Biological) $314.13
- EMGALITY (Drug) $298.19
- Ozempic (Drug) $281.92
- Rybelsus (Drug) $267.16
- Repatha (Biological) $264.97
- FibroScan (Device) $247.07
- MOUNJARO (Drug) $240.09
- AREXVY (Drug) $205.71
- Xofluza (Drug) $205.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Plano
Dr. Mahdi Awwad, M.d, M.D
Family Medicine — Payments: $24,534
Elaine Timm, Md, MD
Family Medicine — Payments: $19,841
Mr. Jose Trevino, Md, MD
Family Medicine — Payments: $18,709
John Moon, M.d, M.D
Family Medicine — Payments: $18,442
Abel Garduno, M.d, M.D
Family Medicine — Payments: $17,192
Dr. Todd Wien, Md, MD
Family Medicine — Payments: $13,547